1994
DOI: 10.1016/0005-2736(94)90344-1
|View full text |Cite
|
Sign up to set email alerts
|

Transport of cycasin by the intestinal Na+/glucose cotransporter

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

1998
1998
2015
2015

Publication Types

Select...
5
1
1

Relationship

3
4

Authors

Journals

citations
Cited by 15 publications
(8 citation statements)
references
References 12 publications
0
8
0
Order By: Relevance
“…Unlike BMAA [41,42], cycasin and MAM readily cross the blood-brain barrier with ϳ5% of either administered agent detected in brain tissue (GK, unpublished data; [43]) ( Table 1). Depending on the route (i.e., oral or topical) of cycad exposure, cycasin gains access to brain tissue via a high-capacity brain endothelial [44,45] or intestinal [46] Na ϩ -dependent glucose transporter (SGLT). Cycasin shows a 100 times greater affinity for the brain endothelial SGLT, suggesting that the genotoxin is rapidly transported by the brain SGLT before it liberates MAM, presumably by enzymatic action of cytosolic (neutral) β-glucosidase.…”
Section: Neurotoxic Properties Of Cycadsmentioning
confidence: 99%
“…Unlike BMAA [41,42], cycasin and MAM readily cross the blood-brain barrier with ϳ5% of either administered agent detected in brain tissue (GK, unpublished data; [43]) ( Table 1). Depending on the route (i.e., oral or topical) of cycad exposure, cycasin gains access to brain tissue via a high-capacity brain endothelial [44,45] or intestinal [46] Na ϩ -dependent glucose transporter (SGLT). Cycasin shows a 100 times greater affinity for the brain endothelial SGLT, suggesting that the genotoxin is rapidly transported by the brain SGLT before it liberates MAM, presumably by enzymatic action of cytosolic (neutral) β-glucosidase.…”
Section: Neurotoxic Properties Of Cycadsmentioning
confidence: 99%
“…Because the neurotoxic properties of cycasin and its active metabolite MAM are poorly understood, initial studies by our group examined the distribution, uptake, and metabolism of cycasin and its active metabolite MAM in rodents. Depending on the route of exposure (topical or oral), cycasin gains entry into the brain by a high-affinity brain endothelial [137] or intestinal [138] Na + -dependent glucose transporter (SGLT). Depending on the route of exposure (topical or oral), cycasin gains entry into the brain by a high-affinity brain endothelial [137] or intestinal [138] Na + -dependent glucose transporter (SGLT).…”
Section: Cycasin/mam: Developmental Neurotoxicitymentioning
confidence: 99%
“…However, in these studies the effect occurred only with oral or parenteral administration in the fi rst 24 hours after birth. There is an active transport mechanism for cycasin across the intestinal mucosa via the Na + /glucose transporter (Hirayama et al 1994), but whether there are factors or conditions that promote access to the central nervous system in adults is not clear. Similar effects have been produced in several animal species, although susceptibility and manifestations vary (Haddad et al 1972).…”
Section: Disease Genesis-cycasmentioning
confidence: 99%